27 min listen
Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy, With Drs. Loretta Nastoupil & Melody Smith
FromThe Hematologist
Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy, With Drs. Loretta Nastoupil & Melody Smith
FromThe Hematologist
ratings:
Length:
14 minutes
Released:
Jul 1, 2022
Format:
Podcast episode
Description
In this installment, Contributing Editor Dr. Loretta Nastoupil has a conversation with Dr. Melody Smith. They discuss a Nature Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy.” In the article, Dr. Nastoupil discusses a study that explored whether antibiotic exposure or fecal microbiome composition was associated with efficacy and toxicity following anti-CD19 chimeric antigen receptor T-cell therapy in adult patients with B-cell malignancies. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.4.202247/485636/Trust-Your-Gut-Changes-in-Intestinal-Microbiome.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Jul 1, 2022
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist